Back to Agenda
Plenary Session 1: International Regulatory Cooperation: Trends and Impacts
Session Chair(s)
Matthew Ryan
Senior Policy Analyst; Policy, Planning and International Affairs Directorate
Health Canada, Canada
Chanez Narimene Kebache, MBA
Director, Global Product Safety & Pharmacovigilance
Canopy Growth Corporation, Canada
Hear from key leaders from international regulators on current trends, activities and the future of collaboration amongst key agencies. International cooperation is having a shifting impact on public policy and drug regulation, and will continue to shape and impact agency activities. Learn about these key initiatives, where agencies are focusing their activities and how interagency collaboration is evolving now and into the future. Attendees will hear about the impacts of these new realities of international regulatory cooperation and what this means for key stakeholders in the development and regulation of health products.
Speaker(s)
Health Canada Perspective
Louise Déry
Health Canada, Canada
Director, Policy, Planning and International Affairs Directorate
EMA Perspective
Sabine Haubenreisser, PhD, MSc
European Medicines Agency, Netherlands
Principal Scientific Administrator, Stakeholders and Communication Division
Embedment of Health Canada National Visiting Expert (NVE) in Pharmacovigilance at European Medicines Agency - Pilot Project (Via Video Communications)
Christopher Turner, MD, FRCPC
Health Canada / EMA, Canada
Director General
Have an account?